Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001219323 | SCV001391256 | uncertain significance | Primary ciliary dyskinesia | 2019-04-06 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant disrupts a region of the protein in which other variant(s) (p.Arg736Gln) have been observed in individuals with DRC1-related conditions (Invitae). This suggests that this may be a clinically significant region of the DRC1 protein. This variant has not been reported in the literature in individuals with DRC1-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change results in a premature translational stop signal in the DRC1 gene (p.Arg694Alafs*30). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 47 amino acids of the DRC1 protein. |
Fulgent Genetics, |
RCV002491682 | SCV002804070 | uncertain significance | Primary ciliary dyskinesia 21 | 2021-12-28 | criteria provided, single submitter | clinical testing |